Clinical Trial

Analysis of Factors Associated With The Occurrence of Amniotic Fluid Entry in Patients Undergoing Caesarean Section

Study acronym: AOFAWTOOAFEIPU
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 28, 2025 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
To compare serum STN （Neuraminic acid-N-acetylgalactose）antigen concentrations in patients undergoing cesarean section and to study the factors associated with amniotic fluid entry.Compare the serum complement C4 concentration in patients in the amniotic fluid admission group with those in the non-admission group to study whether amniotic fluid admission triggers the body's immune response.To record the patients' blood pressure, heart rate, blood oxygen, and the occurrence of related symptoms and adverse reactions at the time of admission, at the time of blood collection, at the time of discharge from the room, and at the time of the occurrence of haemodynamic changes.
Trial Details
NCT Number NCT06991985
Lead Sponsor Second Hospital of Shanxi Medical University
Conditions Amniotic Fluid Embolism
Enrollment 120 participants
Start Date 2025-05-20
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-28